A selective MAOB inhibitor Ro19-6327 potentiates the effects of levodopa on parkinsonism induced by MPTP in the common marmoset
- 31 May 1993
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 32 (5) , 473-477
- https://doi.org/10.1016/0028-3908(93)90172-y
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- [3H]Harman Binding Experiments. II: Regional and Subcellular Distribution of Specific [3H]Harman Binding and Monoamine Oxidase Subtypes A and B Activity in Marmoset and RatJournal of Neurochemistry, 1991
- In-vivo brain dialysis of neurotransmittersTrends in Pharmacological Sciences, 1990
- Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosetsNeuropharmacology, 1989
- Antiparkinsonian activity of (+)‐PHNO in the MPTP‐treated common marmosetMovement Disorders, 1987
- Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmosetEuropean Journal of Pharmacology, 1986
- Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's typeProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1986
- Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline)Acta Neurologica Scandinavica, 1983
- Treatment of Parkinson's disease in early and late phases. Use of pharmacological agents with special reference to deprenyl (selegiline)Acta Neurologica Scandinavica, 1983
- Dopamine is a monoamine oxidase B substrate in manNature, 1977